Cargando…

Increasing Time in Therapeutic Range of Tacrolimus in the First Year Predicts Better Outcomes in Living-Donor Kidney Transplantation

Background: The aim of the present study was to investigate the impact of time in therapeutic range TTR on long-term outcomes of living kidney transplants. Methods: We included 1,241 living kidney transplants and randomized them into development and validation cohorts with a ratio of 2:1. The tacrol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Turun, Yin, Saifu, Jiang, Yamei, Huang, Zhongli, Liu, Jinpeng, Wang, Zhiling, Li, Linde, Zeng, Jun, Fan, Yu, Wang, Xianding, Li, Xingxing, Lin, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933438/ https://www.ncbi.nlm.nih.gov/pubmed/31921171 http://dx.doi.org/10.3389/fimmu.2019.02912

Ejemplares similares

Effect of donor kidney morphology parameters on the prognosis in living kidney transplantation recipients
por: Qiu, Yang, et al.
Publicado: (2020)

Transplant outcomes of 100 cases of living-donor ABO-incompatible kidney transplantation
por: Yin, Saifu, et al.
Publicado: (2022)

Tacrolimus Use and COVID-19 Infection in Patients After Solid Organ Transplantation
por: Yin, Saifu, et al.
Publicado: (2021)

Effect of Donor and Recipient ABH-Secretor Status on ABO-Incompatible Living Donor Kidney Transplantation
por: Zhang, Fan, et al.
Publicado: (2021)

Tacrolimus Trough Level at the First Month May Predict Renal Transplantation Outcomes Among Living Chinese Kidney Transplant Patients: A Propensity Score–Matched Analysis
por: Yin, Saifu, et al.
Publicado: (2019)

Efficacy and safety of stratified versus routine prophylaxis in living kidney transplantation from HBsAg+ donors to HBsAg− recipients: protocol for a multicentre, prospective, observational study
por: Wang, Xianding, et al.
Publicado: (2021)

Ameliorating Metabolic Profiles After Kidney Transplantation: A Protocol for an Open-Label, Prospective, Randomized, 3-Arm, Controlled Trial
por: Yin, Saifu, et al.
Publicado: (2021)

Thymoglobulin vs. ATG-Fresenius as Induction Therapy in Kidney Transplantation: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
por: Song, Turun, et al.
Publicado: (2020)

Factors affecting willingness to receive a kidney transplant among hemodialysis patients in West China: A cross-sectional survey
por: Tan, Qiling, et al.
Publicado: (2017)

Highly individual- and tissue-specific expression of glycoprotein group A and B blood antigens in the human kidney and liver
por: Wang, Xianding, et al.
Publicado: (2021)

Conversion From Calcineurin Inhibitors to Mammalian Target of Rapamycin Inhibitors in Kidney Transplant Recipients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Zeng, Jun, et al.
Publicado: (2021)

Calcineurin Inhibitors Associated Posterior Reversible Encephalopathy Syndrome in Solid Organ Transplantation: Report of 2 Cases and Literature Review
por: Song, Turun, et al.
Publicado: (2016)

A Nomogram Model to Predict Prognosis of Patients With Genitourinary Sarcoma
por: Li, Linde, et al.
Publicado: (2021)

Overexpression of miR-92a attenuates kidney ischemia–reperfusion injury and improves kidney preservation by inhibiting MEK4/JNK1-related autophagy
por: Ma, Ming, et al.
Publicado: (2023)

miR-17-5p attenuates kidney ischemia-reperfusion injury by inhibiting the PTEN and BIM pathways
por: Ma, Ming, et al.
Publicado: (2021)

Is Bigger Better? Living Donor Kidney Volume as Measured by the Donor CT Angiogram in Predicting Donor and Recipient eGFR after Living Donor Kidney Transplantation
por: Ebad, Chaudhry Adeel, et al.
Publicado: (2021)

CYP3A5 Gene-Guided Tacrolimus Treatment of Living-Donor Egyptian Kidney Transplanted Patients
por: Mendrinou, Effrosyni, et al.
Publicado: (2020)

Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation
por: Kim, Hyeyoung, et al.
Publicado: (2014)

Incidence, risk factors, and clinical outcomes of HBV reactivation in non-liver solid organ transplant recipients with resolved HBV infection: A systematic review and meta-analysis
por: Yin, Saifu, et al.
Publicado: (2023)

Post-transplant outcomes in recipients of living donor kidneys and intended recipients of living donor kidneys
por: Dharia, Atit A., et al.
Publicado: (2022)

Clinical experience with once–daily tacrolimus in de novo kidney transplant recipients from living donors in Japan: 1–year follow up
por: Ishida, Kenichiro, et al.
Publicado: (2013)

Adult Living-Donor Kidney Transplantation, Donor Age, and Donor–Recipient Age
por: Hiramitsu, Takahisa, et al.
Publicado: (2021)

GRWR Correlates with the Metabolism of Tacrolimus after Pediatric Living Donor Liver Transplantation According to Donor CYP3A5 Polymorphism
por: Wan, Ping, et al.
Publicado: (2022)

Gut Microbiota and Tacrolimus Dosing in Kidney Transplantation
por: Lee, John R., et al.
Publicado: (2015)

Pharmacokinetics, Pharmacodynamics and Pharmacogenetics of Tacrolimus in Kidney Transplantation
por: Yu, Meng, et al.
Publicado: (2018)

Tacrolimus trough levels in kidney transplant recipients
por: Hwang, Young Hui, et al.
Publicado: (2021)

Impact of ABO incompatible kidney transplantation on living donor transplantation
por: Yu, Ji Hyun, et al.
Publicado: (2017)

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipients with Hepatocellular Carcinoma
por: Sapisochin, Gonzalo, et al.
Publicado: (2022)

Increasing the Supply of Kidneys for Transplantation by Making Living Donors the Preferred Source of Donor Kidneys
por: Testa, Giuliano, et al.
Publicado: (2014)

The impact of CYP3A4 and CYP3A5 genetic variations on tacrolimus treatment of living‐donor Egyptian kidney transplanted patients
por: Wanas, Hanaa, et al.
Publicado: (2023)

Is ABO Incompatible Living Donor Kidney Transplantation in Children a Better Option than the Use of Optimal Grafts From Deceased Donors? A Plea for Better Prioritization of Deceased Kidney Grafts for Children
por: Boyer, Olivia, et al.
Publicado: (2023)

Machine Retrograde Perfusion of Deceased Donor Kidneys: A Prospective Study
por: Zeng, Jun, et al.
Publicado: (2021)

Serum uric acid as a risk factor for rejection after deceased donor kidney transplantation: A mono-institutional analysis of paired kidneys
por: Zhang, Fuxun, et al.
Publicado: (2022)

Genetic Polymorphisms Affecting Tacrolimus Metabolism and the Relationship to Post-Transplant Outcomes in Kidney Transplant Recipients
por: Cheng, Fang, et al.
Publicado: (2021)

Tacrolimus Formulation, Exposure Variability, and Outcomes in Kidney Transplant Recipients
por: Lai, Elaine F., et al.
Publicado: (2022)

A retrospective analysis of the safety and efficacy of low dose tacrolimus (FK506) for living donor liver transplant recipients
por: Wu, Zhengshan, et al.
Publicado: (2013)

Comparing Emotional Adjustment of Living-donor and Deceased-donor Kidney Transplant Patients
por: Lai, Yousheng Lester, et al.
Publicado: (2020)

Motivators and Barriers to Living Donor Kidney Transplant as Perceived by Past and Potential Donors
por: Zazoulina, Julia, et al.
Publicado: (2022)

Socioeconomic deprivation and barriers to live-donor kidney transplantation: a qualitative study of deceased-donor kidney transplant recipients
por: Bailey, Phillippa K, et al.
Publicado: (2016)

A Randomized Pharmacokinetic Study of Generic Tacrolimus Versus Reference Tacrolimus in Kidney Transplant Recipients
por: Alloway, R R, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_3dnqgmumabs9og756lfj19sm8m